This Solicitation opportunity from Department Of Defense was posted on May 26, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

DEXTROSE AND SODIUM

Closed

SPE2DP-26-T-3538Federal

Submission Closed06/01/2026, 05:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412

New

DIBBS

LEVOFLOXACIN TABLETThe contract pertains to the procurement of Levofloxacin tablets, identified by NSN/Part Number 6505-01-444-6632, with a purchase quantity of one unit under request number 7017178498. The solicitation, designated SPE2DP-26-T-3807, was issued by the Defense Logistics Agency on behalf of the Department of Defense with a posting date of June 15, 2026, and a response deadline set for June 22, 2026. This solicitation is categorized as a federal opportunity without specific set-aside conditions or NAICS code information provided. The contract will be performed within the United States, although exact location details are unspecified. The Defense Logistics Agency is managing the acquisition, and the solicitation details are accessible via a designated DIBBS URL for interested parties.

Defense Logistics Agency

POSTED

DEADLINE

Supply of Non-Substitutable Pharmaceutical IngredientsThis contract involves the supply of proprietary, branded pharmaceutical components including TrophAmin®, Plenamine, Nutrilipid®, and SMOF Lipid®, which are essential ingredients used in Total Parenteral Nutrition (TPN) formulations. The contract emphasizes full traceability and compliance with regulatory standards to ensure the safety and quality of these non-substitutable pharmaceutical ingredients. The procurement is managed by the Defense Health Agency Hcd West under the Department of Defense, reflecting the critical nature of these supplies for health services within defense operations. The solicitation was posted on June 15, 2026, with a response deadline set for June 30, 2026. The contract is classified as a subcontract under the NAICS code 325412, which pertains to pharmaceutical manufacturing. The place of performance falls within the 98431 zip code area, though specific city or state details are not disclosed. This contract supports the continued availability of specialized pharmaceutical components necessary for patient nutrition and care in military healthcare settings.

Defense Health Agency Hcd West

POSTED

DEADLINE

Custom Sterile Compounding of Total Parenteral Nutrition (TPN) FormulationsThe contract involves the manufacture and delivery of patient-specific, sterile Total Parenteral Nutrition (TPN) formulations, including branded products such as TrophAmin®, Plenamine, Nutrilipid®, and SMOF Lipid®. These formulations must be provided in volumes ranging from 1000 to over 3000 mL, with an absolute requirement for zero tolerance for deviations, ensuring strict adherence to quality and safety standards. This precision is critical given the nature of the products and their use in patient care. Administered by the Defense Health Agency Hcd West under the Department of Defense, the contract is categorized under NAICS code 325412, which pertains to pharmaceutical and medicine manufacturing. The contract is structured as a subcontract with a deadline for responses set for June 30, 2026. Performance is designated for an area identified by the zip code 98431. The contract underscores the importance of reliable, high-quality sterile compounding to meet defense health requirements with strict compliance to specifications and timelines.

Defense Health Agency Hcd West

POSTED

DEADLINE

Sole Source Total Parenteral Nutrition (TPN) solutions, including TrophAmine, Plenamine, Nutrilipid, and SMOF Lipid same-day delivery, seven days a weekThis contract involves the sole source procurement of Total Parenteral Nutrition (TPN) solutions, specifically including products such as TrophAmine, Plenamine, Nutrilipid, and SMOF Lipid. The key requirement is for same-day delivery, seven days a week, ensuring continuous availability of these critical nutritional solutions. The solicitation number is HT941026N0069, with the notice posted on June 15, 2026, and a response deadline set for June 30, 2026. The contract falls under the NAICS code 325412, associated with pharmaceutical preparation manufacturing, and is issued by the Defense Health Agency located at Camp Pendleton, California. The place of performance is identified within Washington state, ZIP code 98431, indicating where the deliveries or contract services will be conducted. There is no set-aside designation for this procurement, reflecting an open competitive strategy or a direct sole-source justification. Primary and secondary points of contact are provided for further inquiries, with the primary contact being CHA-ON Gordon. The contract aims to support the Department of Defense’s ongoing medical and nutritional needs for personnel, emphasizing timely and reliable supply chain delivery for essential TPN products.

Defense Health Agency Hcd West

POSTED

DEADLINE

6505--Lab Supplies | Radiopharm | 5-Year Indefinite Delivery/Indefinite Quantity (IDIQ) | VA Pittsburgh Healthcare SystemThe contract solicits bids for the supply of laboratory materials related to radiopharmaceuticals under a five-year indefinite delivery, indefinite quantity (IDIQ) agreement for the VA Pittsburgh Healthcare System. The solicitation, identified by the number 36C24426Q0669, invites vendors to provide these specialized lab supplies consistent with NAICS code 325412, which pertains to pharmaceutical preparation manufacturing. The Department of Veterans Affairs, specifically the 244-NETWORK Contract Office 4 located in Pittsburgh, Pennsylvania, is managing this procurement. Vendors interested in participating must submit their proposals by July 10, 2026, with the solicitation having been posted on June 12, 2026. The contract aims to ensure a steady and flexible supply of radiopharmaceutical lab materials to support healthcare operations over a multi-year period, accommodating variable quantities as needed. The primary point of contact for this contract is Christa L. Stine, a contract specialist reachable via email, facilitating communication and clarifications throughout the solicitation process.

244-NETWORK Contract Office 4 (36C244)

POSTED

5 days ago

DEADLINE

in 27 days

AI Contract Overview

This contract pertains to the procurement of sterile, nonpyrogenic dextrose and sodium chloride injection solution for intravenous use, supplied in single-dose, latex-free containers containing DEHP. Each package includes 12 bags or containers, each with a volume of 1,000 mL, containing 5 grams of hydrous dextrose and 0.45 grams of sodium chloride per 100 mL, with water for injection making up the balance. The product must be stored at controlled room temperature (20 to 25°C), protected from excessive heat and freezing, and only used if packaging seals are intact and the solution is clear. The item has a non-extendable 30-month shelf life and is regulated by the FDA. The contract requires delivery within 20 days to the specified destination, Fort Bragg, NC, with transportation arranged by the fastest traceable means excluding parcel post. Packaging should comply with Department of Defense and Federal standards including MIL-STD-129 for marking and labeling, and ASTM D3951 or other specified DLA requirements. The procurement is managed by the Department of Defense’s Medical Supply Chain Pharmacy FSA, with detailed quality and technical requirements incorporated from the DLA master list. Contact and administrative details are provided, with a solicitation response deadline and specified government handling instructions outlined in the contract.

General Info

Procurement of sterile dextrose-sodium chloride IV solution, 1,000 mL bags, 30-month shelf life.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

NAICS

325412 - Pharmaceutical Preparation Manufacturing View NAICS

Place of Performance

BLD A5474 PRATT ST, FORT BRAGG, NC, 28310, US

Set-Aside

NONE

Documents

(1)

RFQ SPE2DP-26-T-3538 Medical Supply Chain Pharma

PDF•rfq

AI Contract Breakdown

Uniform Contract Format

Timeline

PhaseClosed

PostedMay 26

Solicitation

Response DeadlineJun 1

Deadline has passed

Submission Closed

06/01/2026, 05:00:00 PM UTC

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Contacts1 person available

OfficeUS

Organization / Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Office AddressUS

Contacts

DANIEL PORTER

contact@example.gov

+1 (555) 000-0000

Full Description

DEXTROSE AND SODIUM
DEXTROSE AND SODIUM CHLORIDE INJECTION<(>,<)> USP. RX ONLY; STERILE AND
NONPYROGENIC. SINGLE-DOSE CONTAINER. LATEX-FREE; CONTAINS DEHP. FOR
INTRAVENOUS USE ONLY. CONTAINS ONE PORT. EACH 100 ML CONTAINS: HYDROUS
DEXTROSE USP 5 G SODIUM CHLORIDE USP 0.45 G WATER FOR INJECTION USP QS.
UNIT OF ISSUE IS A PACKAGE CONTAINING 12 EACH (BAGS/CONTAINERS). EACH
BAG OR CONTAINER CONTAINS 1,000 ML OR 1 LITER. STORE AT 20 TO 25°C (68
TO 77°F). [SEE USP CONTROLLED ROOM TEMPERATURE.] AVOID EXCESSIVE HEAT
AND PROTECT FROM FREEZING. USE ONLY IF THE SOLUTION IS CLEAR AND SEALS
ARE INTACT.
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description.
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
RS019: Shelf-life requirement RS001 for a TYPE I (CODE P) item with a shelf life of 30 months (non-extendable) applies to this item.
Shall be marked IAW the latest edition of Medical Marking Standard No. 1 https://www.dla.mil/Logistics-Operations/Packaging/
ICU MEDICAL SALES, INC. 85RR5 P/N NDC00990-7926-09
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7016903599 0001 BX 1.000
SPE2DP-26-T-3538
SECTION B
PR: 7016903599 PRLI: 0001 CONT’D
NSN/MATERIAL:6505001161025
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA-QUP:001
IF MATERIAL IS CONSIDERED HAZARDOUS IAW FED-STD-313,
PACKAGE IN ACCORDANCE WITH TQ REQUIREMENT IP025.
IF THE MATERIAL IS NOT CONSIDERED HAZARDOUS, IN ACCORDANCE WITH
FED-STD-313, THE MATERIAL SHALL BE COMMERCIALLY PACKAGED IN ACCORDANCE
WITH ASTM D3951.
All DLA Master List of Technical and Quality Requirements take precedence over ASTM D3951. Mark and label all packaging and packing in accordance with MIL-STD-129. The Unit of Issue (U/I) and Quantity per Unit Pack (QUP) will be as specified in the contract/purchase order. PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
BULK BREAK POINT:
W50YF2
0051 MD CO MEDICAL LOGISTI
AWCF SSF
BLD A5474 PRATT ST
FORT BRAGG NC 28310
US
RDD 555 SHIPMENT. SHIP BY FASTEST TRACEABLE MEANS. DO NOT USE PARCEL POST.
FREIGHT SHIPPING ADDRESS:
W50YF2
0051 MD CO MEDICAL LOGISTI
AWCF SSF
BLD A5474 PRATT ST
FORT BRAGG NC 28310
US
MARKFOR
W50YF2
0051 MD CO MEDICAL LOGISTI
AWCF SSF
BLD A5474 PRATT ST
FORT BRAGG NC 28310
US
M/F: (TCN) W50YF261410004
RDD: 555
PROJ: TP 3
SPE2DP-26-T-3538
SECTION B
PR: 7016903599 PRLI: 0001 CONT’D
SUPP ADD: W9046W SIG: C
FOR GOVERNMENT USE ONLY: (IPD) 12
DIC: A0A DIST: V ADV: 2A FC: Z9
Need Ship Date:00/00/0000 Original Required Delivery Date:05/27/2026
SPE2DP-26-T-3538 NSN/Part Number: 6505-00-116-1025 Quantity: 1 BX Purchase Request: 7016903599QTY: 1 Delivery: 20 days ADO